Multiplex Cytokine Immunoassays
ArticlesBio-Plex Multiplex Assays VideoVideos

Advantages of Multiplexing with Bio-Plex Assays

The Bio-Plex Assay development process is designed to produce high performance multiplex assays. We prioritize sensitivity, broad dynamic range, reproducibility, and shorter incubation times to get you meaningful results faster. Watch this video to learn more about our SMARTS approach to assay development.
READ MORE →
ArticlesBio-Plex Multiplex AssaysProduct Highlights

Introducing the Bio-Plex Pro Human IgG SARS-CoV-2 Serology Assays

Meet our newest product supporting the fight against SARS-CoV-2: the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel. This qualitative multiplex immunoassay kit quickly and efficiently detects IgG antibodies against four SARS-CoV-2 antigens (nucleocapsid, receptor binding domain, spike 1, and spike 2).
READ MORE →
ArticlesBio-Plex Multiplex AssaysProtocols and TipsResearch Highlights

Inflamed in the Brain: A Protocol for Studying Neuroinflammation in Mouse Brain Tissue

Mice are critical model organisms for the study of neuroinflammation. But tissue quantity is often a limiting factor. In a recent paper, researchers describe a protocol for analysis of 33 cytokines and chemokines using only 50 μl of tissue homogenate. The remaining homogenate can be used for RNA extraction or other analysis.
READ MORE →
ArticlesBio-Plex Multiplex AssaysDrug Discovery and DevelopmentGeneral Interest

Multiplex Immunoassays in the Race for a COVID-19 Vaccine

In vaccine development, safety and efficacy are critical. Recent studies have shown that multiplex immunoassays offer a flexible way to monitor immune responses. With the ever-increasing pressure on scientists to develop a practical COVID-19 vaccine, multiplex immunoassays stand out as a proven tool.
READ MORE →
General InterestPast WebinarsWebinars

The Role of Aberrant Cytokine Activity in COVID‑19 Disease

Presented by: Kenneth Oh, PhD, Collaborations, Applications, and New Technology Senior Global Manager
Kelly King, PhD, Field Application Specialist II
Brad VanderWielen, PhD, Field Application Specialist II
Candice Cox, Global Marketing Manager, Immunoassays

View on demand

Emerging reports from the COVID 19 pandemic include a spectrum of patient symptoms due to the host immune response. In this webinar, Bio-Rad scientists discuss early research and nascent hypotheses about the pathophysiology of SARS CoV 2–induced COVID 19 disease by evaluating cytokine and chemokine profiles, the role of chronic inflammation in comorbidities, and the arc of immune resolution of historical virulent pathogens, such as SARS and MERS.

READ MORE →
Bio‑Plex® Multiplex Immunoassay Technology Overview and Setting Up to Run an Assay
Bio-Plex Multiplex AssaysPast WebinarsWebinars

Maximizing Your Mouse: Using the Power of Bio‑Plex to Analyze Mouse Models of Disease and Treatment

Presented by: Daniel Braunschweig, PhD, Proteomics Field Application Scientist Leader

View on demand

This webinar provides an overview of multiplexing technology for research use with mouse samples and highlights the associated benefits to your drug discovery workflow. Specific topics include:

READ MORE →
Bio‑Plex® Multiplex Immunoassay Technology Overview and Setting Up to Run an Assay
Bio-Plex Multiplex AssaysPast WebinarsWebinars

Bio-Plex Manager Software Overview

Presented by: Brett Houser, Bio-Plex Multiplex Immunoassay Product Manager, Protein Quantitation Group

View on demand

Bio-Plex Manager Software is a powerful, intuitive tool used to generate and analyze xMap data. In this webinar you will:

  • Learn how to create an assay protocol
  • Learn how to acquire data
  • Understand basic software parameters
  • Learn about general functionality and navigation
  • Master optimization of standard curves and export data for further analysis

READ MORE →
Multiplex Cytokine Immunoassays
ArticlesBio-Plex Multiplex AssaysFeatured Stories

Multiplex Cytokine Immunoassays — Minimizing Effort, Maximizing Results

Since the first cytokine was identified over 60 years ago, a lot has been done to better understand these molecules. The use of multiplex immunoassays is one such way, though they aren’t considered quite as mainstream yet. Learn about how the SMARTS approach can be used to better align user experience to the performance characteristics of these multiplex assays and hopefully transition them to a more mainstream role in research.
READ MORE →